Company / Current Assets per Share
Corvus Pharmaceuticals, Inc. Current Assets per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.89
FY2024
5-year range
$0.58 / $1.70
FY2020-FY2024
Trend
+53.3%
vs FY2023
Sector context
#199 of 212
Health Care
What the data says
Among 212 Health Care companies, Corvus Pharmaceuticals, Inc. is in the bottom 6% for current assets per share. Current Assets per Share returned to growth in FY2024 after 2 years of decline, reaching $0.89.
Based on SEC 10-K filings.
0.89 in FY2024 with a 5-year CAGR of -19.9%.
Declined from $0.94 to $0.89 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -19.4%
- 5-Year CAGR
- -19.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 212This company $0.89 Sector average $133.20
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2024, current assets per share increased 53.3% year-over-year.
- Ranks #199 out of 212 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2015.
- Lowest current assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.89 | +53.3% |
| FY2023 | $0.58 | -37.9% |
| FY2022 | $0.94 | -45.0% |
| FY2021 | $1.70 | +10.8% |
| FY2020 | $1.54 | -43.1% |
| FY2019 | $2.70 | -35.7% |
| FY2018 | $4.20 | -5.6% |
| FY2017 | $4.45 | -49.5% |
| FY2016 | $8.82 | -96.6% |
| FY2015 | $256.03 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026